Date: Friday 17 Sep 2010
There is no holding back buyers this morning with Johnson & Johnson’s bid for Dutch vaccine group Crucell fuelling a surge in buying.
No recent information was found.
| Business Briefing | 29-Sep-2009 | LA Times |
| Abbott buys Belgian drug unit for $6.6B | 29-Sep-2009 | Wall Street Journal |
| Abbott, Johnson & Johnson bulk up in Europe | 29-Sep-2009 | USA Today |
No recent information was found.
No recent information was found.
No recent information was found.
| Currency | Euro |
| Share Price | € 0.00 |
| Closing Price Change | € 0.00 |
| % Change | 0.00 % |
| 52 Week High | € 0.00 |
| 52 Week Low | € 0.00 |
| Volume | 0 |
| Shares Issued | 82.08m |
You are here: research